Diagnostica Stago UK LTD

Diagnostica Stago UK LTD, a United Kingdom-based for-profit limited liability company, supplies coagulation reagents, laboratory diagnostic materials, and related maintenance services to U.S. military medical facilities in Europe and Africa as a prime contractor on full-and-open delivery orders and indefinite-delivery/indefinite-quantity (IDIQ) contracts, with no subcontractor footprint and no SBA set-aside posture.

The vendor's customer base is highly concentrated in defense medical operations. The Department of the Air Force United States Air Forces in Europe and Africa accounts for 77 awards (82% of the total award count) with $2.2 million in combined potential value, while the Defense Health Agency holds 13 awards ($435 thousand combined potential value) and the Department of the Air Force Defense Finance and Accounting Service holds four awards ($20 thousand). All three rankings align — the USAF's European and African command dominates both volume and dollars. The 48th Medical Group at RAF Lakenheath is the primary customer location, consuming the majority of delivery orders for STAGO brand coagulation reagents and supplies.

Diagnostica Stago UK LTD holds three active parent IDIQ contracts. The most heavily utilized is USAF's Indefinite Delivery Contract FA558720D0004 (originally $369,325 through September 20, 2024), which generated 42 task orders totaling $173 thousand in combined potential value; a second USAF IDIQ, FA558717D0004, produced 30 task orders worth $122 thousand. The vendor also holds a more recent USAF IDIQ, FA558724D0007 (awarded April 19, 2024), with a ceiling of $400,000 through September 20, 2029, against which 13 task orders have been issued for $400 thousand combined potential value. The Defense Health Agency awarded a single-award IDIQ to the vendor on September 21, 2024, valued at $1.2 million through September 20, 2029, for laboratory services and coagulation reagents to the 48th Medical Group.

Recent representative work includes a $317,642.73 firm-fixed-price delivery order from the Defense Health Agency (November 21, 2024) for monthly STAGO reagent supplies to the 48th Medical Group; a $34,531.53 purchase order from the Defense Health Agency (November 3, 2024) for coagulation analyzer maintenance services through November 2, 2029; and a $16,776.19 delivery order from the Defense Health Agency (January 9, 2026) for STAGO reagent replenishment. Individual delivery orders range from under $150 to over $317,000, reflecting routine consumables and periodic maintenance cycles.

Activity has been volatile across the five-year window: 13 awards in 2022, declining to three in 2023, recovering to 13 in 2024, and decelerating to eight in 2025, with three awards recorded in 2026 year to date. The vendor's combined potential value across all 94 prime awards stands at $2.6 million, though only $538 thousand has been obligated to date (21% coverage), indicating a substantial pipeline of unfilled orders under active IDIQs. The vendor competes exclusively in full-and-open procurements without set-aside designation across its entire footprint.

Capability framing is tightly defined by procurement category. The top NAICS codes are Drugs and Druggists' Sundries Merchant Wholesalers (43 awards), Analytical Laboratory Instrument Manufacturing (31 awards), and Surgical and Medical Instrument Manufacturing (16 awards). Under PSC codes, 63 awards fall under In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, with 16 awards in Medical and Surgical Instruments, Equipment, and Supplies, and 10 in Laboratory Equipment and Supplies. This portfolio reflects a specialized, single-customer-class supplier role: Diagnostica Stago UK LTD has no diversification into other federal agencies, no defense prime work outside medical logistics, and no subcontract engagement. Place of performance is exclusively Great Britain.